0001235802-23-000110.txt : 20231108 0001235802-23-000110.hdr.sgml : 20231108 20231108161625 ACCESSION NUMBER: 0001235802-23-000110 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230804 FILED AS OF DATE: 20231108 DATE AS OF CHANGE: 20231108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STANKOVICH THOMAS CENTRAL INDEX KEY: 0001181166 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37897 FILM NUMBER: 231388117 MAIL ADDRESS: STREET 1: 1001 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ReShape Lifesciences Inc. CENTRAL INDEX KEY: 0001427570 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1001 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 BUSINESS PHONE: 949-429-6680 MAIL ADDRESS: STREET 1: 1001 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 FORMER COMPANY: FORMER CONFORMED NAME: OBALON THERAPEUTICS INC DATE OF NAME CHANGE: 20080220 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2023-08-04 0 0001427570 ReShape Lifesciences Inc. RSLS 0001181166 STANKOVICH THOMAS 1001 CALLE AMANECER SAN CLEMENTE CA 92673 0 1 0 0 Chief Financial Officer 0 Common Stock, $0.001 par value per share 2023-08-04 4 S 0 108 1.43 D 23276 D Common Stock, $0.001 par value per share 2023-08-24 4 S 0 39 1.42 D 23237 D Common Stock, $0.001 par value per share 2023-09-01 4 S 0 118 0.89 D 23119 D Common Stock, $0.001 par value per share 2023-10-11 4 S 0 39 0.93 D 23080 D Common Stock, $0.001 par value per share 2023-10-25 4 S 0 131 0.27 D 22949 D On July 22, 2021, Mr. Stankovich was awarded an aggregate of 7,455 restricted stock units, all of which, including the unvested portion, were reported on a Form 4 filed on September 17, 2021. The shares reported under this Form 4 as being disposed of were sold to cover taxes in connection with the vesting of a portion of those previously reported restricted stock units. /s/ Thomas Stankovich 2023-11-08